Ablation of iNOS delays cardiac contractile dysfunction in chronic hypertension

Frontiers in Bioscience - Elite

Volumn 2 E, Issue 1, 2010, Pages 312-324

  Dias, Fernando A L ^a,b   Urboniene, Dalia ^a   Yuzhakova, Milana A ^a   Biesiadecki, Brandon J ^a   Pena, James R ^a   Goldspink, Paul H ^a   Geenen, David L ^a   Wolska, Beata M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Aortic banding; Beta adrenergic stimulation; Hypertrophy; Nitric oxide

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MYOSIN HEAVY CHAIN; NOS2 PROTEIN, MOUSE; NOS3 PROTEIN, MOUSE;

ANALYSIS OF VARIANCE; ANIMAL; AORTA; ARTICLE; ECHOCARDIOGRAPHY; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; HEART CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PAPILLARY MUSCLE; HEMODYNAMICS; HYPERTENSION; LIGATION; MALE; METABOLISM; MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; AORTA; BIOLOGICAL MARKERS; BLOTTING, WESTERN; ECHOCARDIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE; HEMODYNAMICS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LIGATION; MALE; MICE; MYOCARDIAL CONTRACTION; MYOSIN HEAVY CHAINS; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PAPILLARY MUSCLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954525347     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. R. A. Kelly, J. L. Balligand, and T. W. Smith. Nitric oxide and cardiac function. Circ Res 79, 363-380 (1996) (Pubitemid 26276897)
2. J. M. Hare, M. M. Givertz, M. A. Creager, and W. S. Colucci. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-Adrenergic inotropic responsiveness. Circulation 97, 161-166 (1998) (Pubitemid 28124673)
3. M. O. Stojanovic, M. T. Ziolo, G. M. Wahler, and B. M. Wolska. Anti-Adrenergic effects of nitric oxide donor SIN-1 in rat cardiac myocytes. Am J Physiol Cell Physiol 281, C342-C349 (2001)
4. M. T. Ziolo, L. S. Maier, V. Piacentino, III, J. Bossuyt, S. R. Houser, and D. M. Bers. Myocyte nitric oxide synthase 2 contributes to blunted beta-Adrenergic response in failing human hearts by decreasing Ca2+ transients. Circulation 109, 1886-1891 (2004) (Pubitemid 38509124)
5. W. J. Paulus, P. J. Vantrimpont, and A. M. Shah. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89, 2070-2078 (1994) (Pubitemid 24142783)
6. N. Suto, A. Mikuniya, T. Okubo, H. Hanada, N. Shinozaki, and K. Okumura. Nitric oxide modulates cardiac contractility and oxygen consumption without changing contractile efficiency. Am J Physiol 275, H41-H49 (1998)
7. Y. Chen, J. H. Traverse, R. Du, M. Hou, and R. J. Bache. Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation 106, 273-279 (2002) (Pubitemid 34761311)
8. L. Xu, J. P. Eu, G. Meissner, and J. S. Stamler. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279, 234-237 (1998) (Pubitemid 28103882)
9. L. A. Barouch, R. W. Harrison, M. W. Skaf, G. O. Rosas, T. P. Cappola, Z. A. Kobeissi, I. A. Hobai, C. A. Lemmon, A. L. Burnett, B. O'Rourke, E. R. Rodriguez, P. L. Huang, J. A. Lima, D. E. Berkowitz, and J. M. Hare. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416, 337-339 (2002)
10. O. Feron, L. Belhassen, L. Kobzik, T. W. Smith, R. A. Kelly, and T. Michel. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271, 22810-22814 (1996) (Pubitemid 26304729)
11. K. Y. Xu, D. L. Huso, T. M. Dawson, D. S. Bredt, and L. C. Becker. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 96, 657-662 (1999) (Pubitemid 29061264)
12. O. Gealekman, Z. Abassi, I. Rubinstein, J. Winaver, and O. Binah. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-Adrenergic hyporesponsiveness in rats with experimental volumeoverload heart failure. Circulation 105, 236-243 (2002) (Pubitemid 34084325)
13. S. Yamamoto, H. Tsutsui, H. Tagawa, K. Saito, M. Takahashi, H. Tada, M. Yamamoto, M. Katoh, K. Egashira, and A. Takeshita. Role of myocyte nitric oxide in betaadrenergic hyporesponsiveness in heart failure. Circulation 95, 1111-1114 (1997) (Pubitemid 27097817)
14. I. N. Mungrue, M. Husain, and D. J. Stewart. The role of NOS in heart failure: lessons from murine genetic models. Heart Fail Rev 7, 407-422 (2002) (Pubitemid 35396472)
15. V. E. Laubach, E. G. Shesely, O. Smithies, and P. A. Sherman. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 92, 10688-10692 (1995)
16. H. A. Rockman, R. S. Ross, A. N. Harris, K. U. Knowlton, M. E. Steinhelper, L. J. Field, J. Ross, Jr., and K. R. Chien. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88, 8277-8281 (1991) (Pubitemid 21915339)
17. B. B. Roman, D. L. Geenen, M. Leitges, and P. M. Buttrick. PKC-beta is not necessary for cardiac hypertrophy. Am J Physiol Heart Circ Physiol 280, H2264-H2270 (2001)
18. D. Urboniene, F. A. Dias, J. R. Pena, L. A. Walker, R. J. Solaro, and B. M. Wolska. Expression of slow skeletal troponin I in adult mouse heart helps to maintain the left ventricular systolic function during respiratory hypercapnia. Circ Res 97, 70-77 (2005) (Pubitemid 40982324)
19. P. H. Goldspink, D. E. Montgomery, L. A. Walker, D. Urboniene, R. D. McKinney, D. L. Geenen, R. J. Solaro, and P. M. Buttrick. Protein kinase C epsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res 95, 424-432 (2004) (Pubitemid 39100461)
20. B. M. Wolska, K. Vijayan, G. M. Arteaga, J. P. Konhilas, R. M. Phillips, R. Kim, T. Naya, J. M. Leiden, A. F. Martin, P. P. de Tombe, and R. J. Solaro. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions. J Physiol 536, 863-870 (2001) (Pubitemid 33019421)
21. K. J. Alden, P. H. Goldspink, S. W. Ruch, P. M. Buttrick, and J. Garcia. Enhancement of L-Type Ca2+ current from neonatal mouse ventricular myocytes by constitutively active PKC-betaII. Am J Physiol Cell Physiol 282, C768-C774 (2002) (Pubitemid 34663139)
22. F. A. Dias, L. A. Walker, G. M. Arteaga, J. S. Walker, K. Vijayan, J. R. Pena, Y. Ke, R. T. Fogaca, A. Sanbe, J. Robbins, and B. M. Wolska. The effect of myosin regulatory light chain phosphorylation on the frequencydependent regulation of cardiac function. J Mol Cell Cardiol 41, 330-339 (2006) (Pubitemid 44080223)
23. C. M. Warren and M. L. Greaser. Method for cardiac myosin heavy chain separation by sodium dodecyl sulfate gel electrophoresis. Anal Biochem 320, 149-151 (2003) (Pubitemid 36937078)
24. N. G. Vejlstrup, A. Bouloumie, S. Boesgaard, C. B. Andersen, J. E. Nielsen-Kudsk, S. A. Mortensen, J. D. Kent, D. G. Harrison, R. Busse, and J. Aldershvile. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. J Mol Cell Cardiol 30, 1215-1223 (1998) (Pubitemid 28327789)
25. R. D. Patten, D. Denofrio, M. El-Zaru, R. Kakkar, J. Saunders, F. Celestin, K. Warner, H. Rastegar, K. R. Khabbaz, J. E. Udelson, M. A. Konstam, and R. H. Karas. Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart. J Am Coll Cardiol 45, 1419-1424 (2005) (Pubitemid 40615612)
26. D. S. Winlaw, G. A. Smythe, A. M. Keogh, C. G. Schyvens, P. M. Spratt, and P. S. Macdonald. Increased nitric oxide production in heart failure. Lancet 344, 373-374 (1994) (Pubitemid 24248210)
27. Q. Feng, X. Lu, D. L. Jones, J. Shen, and J. M. Arnold. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104, 700-704 (2001) (Pubitemid 32738526)
28. F. Sam, D. B. Sawyer, Z. Xie, D. L. Chang, S. Ngoy, D. A. Brenner, D. A. Siwik, K. Singh, C. S. Apstein, and W. S. Colucci. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res 89, 351-356 (2001) (Pubitemid 34132674)
29. T. Saito, F. Hu, L. Tayara, L. Fahas, H. Shennib, and A. Giaid. Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure. Am J Physiol Heart Circ Physiol 283, H339-H345 (2002) (Pubitemid 34705356)
30. Y. H. Liu, O. A. Carretero, O. H. Cingolani, T. D. Liao, Y. Sun, J. Xu, L. Y. Li, P. J. Pagano, J. J. Yang, and X. P. Yang. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol 289, H2616-H2623 (2005) (Pubitemid 41698578)
31. G. A. Haywood, P. S. Tsao, H. E. Der Leyen, M. J. Mann, P. J. Keeling, P. T. Trindade, N. P. Lewis, C. D. Byrne, P. R. Rickenbacher, N. H. Bishopric, J. P. Cooke, W. J. McKenna, and M. B. Fowler. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93, 1087-1094 (1996) (Pubitemid 26087012)
32. M. Fukuchi, S. N. Hussain, and A. Giaid. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-Adrenergic receptor therapy. Circulation 98, 132-139 (1998) (Pubitemid 28317893)
33. M. Thoenes, U. Forstermann, W. R. Tracey, N. M. Bleese, A. K. Nussler, H. Scholz, and B. Stein. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 28, 165-169 (1996) (Pubitemid 26110462)
34. M. Satoh, M. Nakamura, G. Tamura, S. Makita, I. Segawa, A. Tashiro, R. Satodate, and K. Hiramori. Inducible nitric oxide synthase and tumor necrosis factoralpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 29, 716-724 (1997) (Pubitemid 27128242)
35. I. B. Buchwalow, W. Schulze, P. Karczewski, M. M. Kostic, G. Wallukat, R. Morwinski, E. G. Krause, J. Muller, M. Paul, J. Slezak, F. C. Luft, and H. Haller. Inducible nitric oxide synthase in the myocard. Mol Cell Biochem 217, 73-82 (2001) (Pubitemid 32184458)
36. Y. Sun, O. A. Carretero, J. Xu, N. E. Rhaleb, F. Wang, C. Lin, J. J. Yang, P. J. Pagano, and X. P. Yang. Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension. Hypertension 46, 1355-1361 (2005) (Pubitemid 43189735)
37. P. Zhang, X. Xu, X. Hu, E. D. van Deel, G. Zhu, and Y. Chen. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 100, 1089-1098 (2007) (Pubitemid 46598934)
38. S. P. Jones, J. J. Greer, P. D. Ware, J. Yang, K. Walsh, and D. J. Lefer. Deficiency of iNOS does not attenuate severe congestive heart failure in mice. Am J Physiol Heart Circ Physiol 288, H365-H370 (2005) (Pubitemid 40023868)
39. H. A. Rockman, S. Ono, R. S. Ross, L. R. Jones, M. Karimi, V. Bhargava, J. Ross, Jr., and K. R. Chien. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A 91, 2694-2698 (1994) (Pubitemid 24139414)
40. M. T. Ziolo, H. Katoh, and D. M. Bers. Expression of inducible nitric oxide synthase depresses beta-Adrenergicstimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation 104, 2961-2966 (2001) (Pubitemid 33139110)
41. T. Damy, P. Ratajczak, A. M. Shah, E. Camors, I. Marty, G. Hasenfuss, F. Marotte, J. L. Samuel, and C. Heymes. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363, 1365-1367 (2004) (Pubitemid 38529877)
42. B. Stein, T. Eschenhagen, J. Rudiger, H. Scholz, U. Forstermann, and I. Gath. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. J Am Coll Cardiol 32, 1179-1186 (1998) (Pubitemid 28522371)
43. P. B. Massion, C. Dessy, F. Desjardins, M. Pelat, X. Havaux, C. Belge, P. Moulin, Y. Guiot, O. Feron, S. Janssens, and J. L. Balligand. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-Adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 110, 2666-2672 (2004) (Pubitemid 39453017)
44. F. Brunner, P. Andrew, G. Wolkart, R. Zechner, and B. Mayer. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104, 3097-3102 (2001) (Pubitemid 34014064)
45. E. J. Danson, Y. H. Zhang, C. E. Sears, A. R. Edwards, B. Casadei, and D. J. Paterson. Disruption of inhibitory Gproteins mediates a reduction in atrial beta-Adrenergic signaling by enhancing eNOS expression. Cardiovasc Res 67, 613-623 (2005) (Pubitemid 41033357)
46. I. Fleming, B. Fisslthaler, S. Dimmeler, B. E. Kemp, and R. Busse. Phosphorylation of Thr495 regulates Ca2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88, E68-E75 (2001)